[HTML][HTML] The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins

EM Rosenberg, X Jian, O Soubias, HY Yoon… - Journal of Biological …, 2023 - ASBMB
The ADP-ribosylation factor (Arf) GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …

[HTML][HTML] The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins

EM Rosenberg Jr, X Jian, O Soubias… - The Journal of …, 2023 - ncbi.nlm.nih.gov
The ADP-ribosylation factor (Arf) GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …

The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins.

EM Rosenberg Jr, X Jian, O Soubias… - The Journal of …, 2023 - europepmc.org
The ADP-ribosylation factor (Arf) GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …

The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins

EM Rosenberg Jr, X Jian, O Soubias… - The Journal of … - pubmed.ncbi.nlm.nih.gov
The ADP-ribosylation factor (Arf) GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …

[HTML][HTML] The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins

EM Rosenberg Jr, X Jian, O Soubias, HY Yoon… - Journal of Biological …, 2023 - Elsevier
The ADP-ribosylation factor (Arf) GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …

The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins.

EM Rosenberg Jr, X Jian, O Soubias… - The Journal of …, 2023 - europepmc.org
The ADP-ribosylation factor (Arf) 2 GTPases and their regulatory proteins are implicated in
cancer progression. NAV-2729 was previously identified as a specific inhibitor of Arf6 that …